Jung-Im Shin

33PUBLICATIONS
61CO-AUTHORS
PharmacogenomicsMolecular targetsBiomechanicsDisease surveillanceEconomic models and forecasting
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|Mar 20, 2026
Glucagon-like peptide-1 receptor agonists for major cardiovascular and kidney outcomes in type 1 diabetes.

Yunwen Xu, Natalie Daya Malek, Alexander R Chang

|Jan 02, 2026
Age disparities in SGLT2 inhibitor prescription among people with type 2 diabetes: The role of frailty and sex.

Changyuan Yang, Petra Denig, Lynne Chepulis

|Dec 16, 2025
A Target Trial Emulation Study of SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Combination Therapy in Preventing Kidney Failure in Type 2 Diabetes.

Matthew F Blum, Sneha Mehta, Aditya Surapaneni

|Jul 22, 2025
Real-World Experience with an Electronic Patient-Reported Outcome Measure in Care of Patients with Non-Dialysis-Dependent CKD.

Dipal M Patel, Dingfen Han, Mary Ann C Stephens

|Jul 03, 2025
Promising Real-World Data on Glucagon-Like Peptide-1 Receptor Agonists in Dialysis.

Jung-Im Shin, Alexander R Chang

Pageof 6